Epinephrine hyperglycemia with particular reference to the arteriovenous blood sugar difference in hepatic disease

被引：5

作者：

Cantarow, A

Ricchiuti, G

机构：

[1] Jefferson Hosp, Dept Med, Philadelphia, PA USA

[2] Jefferson Hosp, Lab Biochem, Philadelphia, PA USA

来源：

关键词：

D O I：

10.1172/JCI100598

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：461 / 478

页数：18

共 37 条

[1]

ALTHAUSEN T. L., 1931, ARCH INTERNAL MED, V48, P667

[2]

Asher L, 1929, BIOCHEM Z, V206, P369

[3]

Benedict SR, 1931, J BIOL CHEM, V92, P141

[4]

BENEDICT SR, 1931, J BIOL CHEM, V92, P156

[5]

Blum F, 1901, DTSCH ARCH KLIN MED, V71, P146

[6]

Bodo RC, 1933, AM J PHYSIOL, V103, P5

[7] Glycogenolysis due to epinephrine in hepatic disease [J].

Brill, S .

[8]

BRILL S, 1928, ARCH PATH, V5, P1148

Cantarow, A .

[10] Ether hyperglycemia - With special reference to hepatic disease [J].

Cantarow, A ;

Gehret, AM .